Fortis Healthcare Revenue History — Quarter by Quarter

Fortis Healthcare's revenue moved from ₹1,657 Cr in Q1 FY24 to ₹2,265 Cr in Q3 FY26, a 36.7% change over 11 quarters. The table keeps each quarter linked back to the underlying earnings page.

Revenue by Quarter

Quarter	Revenue (₹ Cr)	YoY Change
Q3 FY26	₹2,265 Cr	+17.5%
Q2 FY26	₹2,331 Cr	+17.3%
Q1 FY26	₹2,167 Cr	+16.6%
Q4 FY25	₹2,007 Cr	+12.5%
Q3 FY25	₹1,928 Cr	+14.8%
Q2 FY25	₹1,988 Cr	+12.3%
Q1 FY25	₹1,859 Cr	+12.2%
Q4 FY24	₹1,786 Cr	+8.7%
Q3 FY24	₹1,680 Cr	+8%
Q2 FY24	₹1,770 Cr	+10.1%
Q1 FY24	₹1,657 Cr	+11.4%

What management said about revenue

Q3 FY26 · ARPOB growth of 4-5% expected for next two years

Management expects ARPOB to grow 4-5% annually, driven by case mix and price increases.

Q3 FY26 · IHH equity infusion likely in 3-6 months

IHH may infuse fresh equity via preferential allotment to strengthen balance sheet for growth.

Q2 FY26 · Organic bed addition of 400-500 beds in FY26

Company added 550 operational beds in H1 FY26 and expects full-year addition of 400-500 beds.

Q2 FY26 · ARPOB growth of 5-6% in H2 FY26

Management expects ARPOB growth of 5-6% in second half, driven by mix improvement and robotic surgeries.

Q1 FY26 · Diagnostics revenue growth to reach low double-digits in 6-8 quarters

Agilus expects revenue growth to trend in the high single-digits over the next few quarters, moving to early double-digits in 6-8 quarters.

Q4 FY25 · Hospital revenue growth of 14-15% in FY26

Management expects hospital revenue to grow 14-15% in FY26, with ARPOB growth of 5-6% and volume growth making up the balance.

Q4 FY25 · Agilus double-digit revenue growth and 23% EBITDA margin in FY26

Management targets double-digit revenue growth for Agilus in FY26, with EBITDA margin (net) around 23%, moving towards 25% in a couple of years.

Q3 FY25 · Manesar greenfield to break even by Q1 FY26

The Manesar facility, currently at INR 5 crore monthly revenue, is expected to break even at INR 9 crore per month by Q1 FY26.

Q3 FY25 · Agilus to reach industry growth of 8-10% by Q2 FY26

Agilus expects to return to industry-level growth of 8-10% by Q2 FY26, driven by volume growth.

Q2 FY25 · Capex of INR 800-900 crore per year for FY25 and FY26

Annual capex includes maintenance and growth capex for both years, supporting brownfield expansions and equipment upgrades.

Q1 FY25 · Agilus to return to industry growth by next year

Management expects Agilus to consolidate during FY25 and return to industry-level growth in FY26, driven by brand recovery and network expansion.

Q4 FY24 · Medium-term ARPOB growth of 4-5%

ARPOB growth expected to moderate to 4-5% in medium term from 10.8% in FY24, driven by 2-2.5% price increases and case mix improvement.